11/14/2024 8:00 PM | Krystal Biotech (Subject) Redmile Group, LLC (Filed by)
| Form SC 13G/A | |
11/04/2024 7:04 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 7:05 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/16/2024 11:28 AM | Krystal Biotech (Subject) STATE STREET CORP (Filed by)
| Form SC 13G | |
09/13/2024 4:41 PM | Krystal Biotech (Issuer) ROSSI DINO A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:44 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:45 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
09/12/2024 3:33 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024 3:33 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024 3:31 PM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 7:03 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/05/2024 7:08 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/10/2024 12:14 PM | Krystal Biotech (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) Krystal Biotech (Subject)
| Form SC 13G/A | |
07/01/2024 6:32 PM | Krystal Biotech (Issuer) Mason Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:34 PM | JANNEY DANIEL (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:37 PM | Gangolli Julian S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:21 PM | Krystal Biotech (Issuer) ROSSI DINO A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:24 PM | Krystal Biotech (Issuer) Sutherland Everett Rand (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/01/2024 6:29 PM | Krystal Biotech (Issuer) Mazzacco Catherine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 7:31 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/11/2024 7:33 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 5:17 PM | Gangolli Julian S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 3:38 PM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/20/2024 3:51 PM | Gangolli Julian S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/06/2024 7:04 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2024 7:17 AM | Krystal Biotech (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/04/2024 3:08 PM | Krystal Biotech (Filer)
| Form DEF 14A | |
04/04/2024 3:09 PM | Krystal Biotech (Filer)
| Form DEFA14A | |
03/11/2024 7:24 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 7:27 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 3:36 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/11/2024 3:37 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024 7:20 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:09 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:13 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 7:16 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:39 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:33 PM | Krystal Biotech (Issuer) ROMANO KATHRYN (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2024 8:36 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2024 12:35 PM | Krystal Biotech (Subject) ROMANO KATHRYN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide.
It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late. |
02/26/2024 6:59 AM | Krystal Biotech (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2024 7:04 AM | Krystal Biotech (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/26/2024 6:49 AM | Krystal Biotech (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 8:25 AM | Avoro Capital Advisors LLC (Filed by) Krystal Biotech (Subject)
| Form SC 13G/A | |
01/29/2024 2:26 PM | Krystal Biotech (Subject)
| Form SC 13G/A | |
01/24/2024 4:44 PM | Krystal Biotech (Issuer) Romano Kathryn (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 10:43 AM | Krystal Biotech (Subject) Romano Kathryn (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:17 PM | Krishnan Krish S (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 4:23 PM | Krishnan Suma (Reporting) Krystal Biotech (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 3:19 PM | Krishnan Krish S (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 3:20 PM | Krishnan Suma (Reporting) Krystal Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |